{
  "@context": "https://schema.org",
  "@graph": [
    {
      "@type": "Organization",
      "@id": "https://knoppbio.com/#organization",
      "name": "Knopp Biosciences",
      "url": "https://knoppbio.com/",
      "description": "Knopp Biosciences | Life Changing Medicine Home Knopp Biosciences Modified LP for Portal Select Page Knopp Biosciences LLC is a privately held company managing a portfolio of future milestone payments and product royalties. Founded in 2004, the company sold and/or spun off its two drug pipelines in 2022. Knopp’s clinical stage Kv7 platform, small-molecule treatments for epilepsy and other hyperexcitability disorders, was acquired by Biohaven Pharmaceuticals and is currently in late stage clinical trials ( www.biohavenpharma.com )."
    },
    {
      "@type": "WebPage",
      "@id": "https://directory.websdocs.com/business/knopp-biosciences#asg",
      "name": "Knopp Biosciences ASG Directory Profile",
      "url": "https://directory.websdocs.com/business/knopp-biosciences",
      "isPartOf": {
        "@id": "https://knoppbio.com/#organization"
      },
      "description": "Public business information published by the WebsDocs ASG Directory."
    }
  ]
}